Cancer Research Annual Meeting 2010  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 35, 99-105, January 1, 1975]
© 1975 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Misra, N. C.
Right arrow Articles by Roberts, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Misra, N. C.
Right arrow Articles by Roberts, D.

Inhibition by 4'-Demethyl-epipodophyllotoxin 9-(4,6-O-2-Thenylidene-ß-D-glucopyranoside) of Human Lymphoblast Cultures in G2 Phase of the Cell Cycle1

Naresh C. Misra2 and DeWayne Roberts

Laboratories of Pharmacology, St. Jude Children's Research Hospital, Memphis, Tennessee 38101

4'-Demethyl-epipodophyllotoxin 9-(4,6-O-2-thenylidene-ß-D-glucopyranoside) is a semisynthetic derivative of podophyllotoxin with oncolytic activity against a variety of neoplasms. Unlike the parent compound and other derivatives, which cause metaphase arrest, 4'-Demethyl-epipodophyllotoxin 9-(4,6-O-2-thenylidene-ß-D-glucopyranoside) apparently blocks the entry of CCRF-CEM cells into mitosis by inhibiting cells in the G2 phase of the cell cycle. The inhibition of precursor incorporation into DNA, RNA, and protein, if observed, was delayed and probably secondary to inhibition of cells in the G2 phase of the cell cycle.

1 Supported by USPHS Cancer Research Grant CA-08480, Research Project Grant CA-12732 from the National Cancer Institute, and ALSAC.

2 Karnofsky Fellow at St. Jude Children's Research Hospital.

Received 7/29/74. Accepted 10/ 8/74.




This article has been cited by other articles:


Home page
JCBHome page
P. R. Andreassen, F. B. Lacroix, and R. L. Margolis
Chromosomes with Two Intact Axial Cores Are Induced by G2 Checkpoint Override: Evidence That DNA Decatenation Is not Required to Template the Chromosome Structure
J. Cell Biol., January 13, 1997; 136(1): 29 - 43.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1975 by the American Association for Cancer Research.